Still No Appetite At US FDA For CBD In Food
Beverages Also Remain Missing From Agency Menu For Lawful Hemp Use
Executive Summary
Three years after similar warnings to make same impression, FDA warns five firms about using in food or beverage products CBD, the cannabinoid most commonly found in US, and delta-8 THC, a subject of ongoing discussion over whether it qualifies as hemp. One firm also warned about CBD in sunscreen.
You may also be interested in...
Dietary Ingredient Studies For Health Benefits Could Be Fenced In By US FDA IND Proposal
Proposed rule introduces two exemptions agency would allow from needing IND clearance for clinical investigations to evaluate food, supplements or cosmetics. Both begin with basic requirement of trial not intended to support drug development plan or labeling change that would make a food, dietary ingredient or cosmetic an unlawfully marketed drug.
CBD Will Be US FDA’s ‘One’ Lawful Hemp Compound, House Appropriators Anticipate
Reference in report accompanying House Appropriation Committee bill for FDA FY2023 budget isn’t binding and wasn’t appropriators’ first mention of agency’s response to de-scheduling hemp as a controlled substance. But their ’ statement was more pointed than in previous appropriation reports.
First US Warnings On Drug Claims By Delta-8 THC Supplements Also Describe Safety Concerns
Announcement and warnings, in addition to noting firms’ violative drug and disease claims, explain differences between delta-8 THC and other hemp-derived cannabinoids intended for de-scheduling as controlled substances in 2018 farm bill.